Revised MenACWY Vaccination Strategy for Adoles...

By HEOR Staff Writer

February 18, 2026

G-BA Approves MenACWY Vaccination Strategy Shift for Adolescents Germany's Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) has approved key amendments to t...
Glofitamab Cost-Effectiveness: Conditional Reimbursement Insights for DLBCL T...
NICE Endorses Pegzilarginase for Treating Arginase Deficiency
Transformative PBM Reform Legislation Signed into Law
Disrupting Prescription Drug Pricing: Mark Cuban’s Cost-Plus Vision
Pharmaceutical Tender Investigation Sparks Regulatory Scrutiny in South Africa
South Africa Health Reform: Navigating Innovations and Challenges for 2026
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
European Pharma Competitiveness: A Cornerstone for EU Economic Resilience
Tislelizumab NSCLC Inclusion Recommended for Dutch Health Package
Launch of TrumpRx Drug Pricing: Savings on Essential Medications
Ozempic Public Funding Approval in Portugal: Key Insights and Implications
NICE Endorses Dupilumab for Eosinophilic COPD Treatment